Original Contribution

Local effects
In all patients with stage III cancer, a CR was obtained. However, in the 2 patients with stage IVa cancer showing prolongation of the total treatment period, adequate effects could not be observed, and only a PR was obtained. In these patients, since a vesicovaginal fistula developed during the treatment, the irradiation dose was lower than that routinely used for stage Wa. Thus, the response rate was 100%. In the patients showing a CR, no local recurrence in the uterus was observed during the course.
Late results
As Table II shows, the entire course could be followed up in all patients except 1. The mean follow-up period was 43.7 months. The 5-year survival rate was 50% for stage III and 33% for stage IVa. However, since the number of the subjects was small, these figures were considered to be only reference values because the confidence interval was wide as shown by the range of errors expressed as the standard deviation. Concerning the association between the development mechanism of metastases and prognosis (Table IV) , the late results were relatively good in patients who did not develop hematogenous metastasis (P = 0.07). 
Acute side effects of thermotherapy
Almost all patients developed heat sensation in the skin and slight pain in some sessions . In 1 patient, umbilical burn injury occurred, but thermotherapy could be continued without suspension using Xylocaine gauze. In another patient, subcutaneous induration was observed on the oral side of the pubic bone. In this patient, subcutaneous fat was thick, and treatment could be performed after a 2-week suspension period using a physiological saline pad (Table HI) .
Discussion
Radiotherapy for uterine cancer has reached the limitations in terms of irradiation techniques°. However , for advanced cervical cancer, satisfactory cure rates have not been obtained by radiotherapy, and other methods such as chemotherapy have been used in combination with radiotherapy 9,10). Thermotherapy is a useful method for intractable advanced cancer. The JASTRO Thermotherapy Research Group, which analyzed the effects of thermoradiotherapy for cervical cancer, found increases in the local control rate and the survival rate 6).
The effects of thermoradiotherapy on the local control of cervical cancer may have been established, but its effects on late results have still been controversial3-7). In this study, we evaluated 10 patients 5 years or more after the initiation of thermotherapy and observed satisfactory local effects at least in the stageIII patients. However, no significant effects on late results were observed. Our results suggested that the prognosis is markedly affected by the presence or absence of distant metastasis. This problem can not be coped with thermoradiotherapy that is originally local therapy. In the stage III patients, no local recurrence was observed, indicating adequate local control. Therefore, methods or controlling distant metastasis are necessary.
The course of the patients who died of cancer was evaluated in terms of distant metastasis. These patients died of distant metastasis of cancer 1 -3 years after the initiation of treatment. Though the possibility of induction of metastasis by thermotherapy can not be excluded, it is more likely that subclinical metastatic lesions were already present at the time of treatment . If so, prophylactic systemic chemotherapy is necessary 9,10). Attempts of thermo-chemo-radiotherapy have already been performed 3) , and "prophylactic" in these attempts indicates relatively mild chemotherapy that can be used in combination with thermoradiotherapy. The late results of at least stage III cancer may be markedly improved by the combination between standard radiotherapy used for stage II cervical cancer and mild thermochemotherapy because of its established local effects and the control of distant metastasis by chemotherapy.
Based on these principles, we perform thermo-radio-chemotherapy according to the following protocol:
thermochemotherapy, 60-min heating once a week with Paraplatin (100 mg); radiotherapy, whole pelvis 4port irradiation 5 times a week (25.4 Gy/14 fs) followed by the combination between pelvic irradiation with a central shield 3 times a week (25.4 Gy/14 fs) and intracavitary irradiation (point A , 4 Gy) using a cobalt source 2 times a week (total 7 times) during the same 4-week period . Though this therapy has adequate local effects, we have not reached a conclusion concerning its effects on late results .
Thermoradiotherapy for uterine cervical cancer has marked local effects, but its effects on late results have been suggested to be questionable. This indicates the limitations of thermoradiotherapy that is originally local therapy. We evaluated patients who underwent thermoradiotherapy at our institution and suggested the usefulness of prophylactic chemotherapy for improving prognosis. Concerning prophylactic chemotherapy, we consider relatively mild chemotherapy that is used in thermoradiochemotherapy .
Excellent results have already been reported by this method. However, further studies are necessary to reach a conclusion.
